Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Deloitte
Harvard Business School
Johnson and Johnson
Express Scripts
Daiichi Sankyo
QuintilesIMS
Teva
Baxter
AstraZeneca

Generated: January 23, 2018

DrugPatentWatch Database Preview

TECHNETIUM TC-99M PENTETATE KIT Drug Profile

« Back to Dashboard

Which patents cover Technetium Tc-99m Pentetate Kit, and what generic alternatives are available?

Technetium Tc-99m Pentetate Kit is a drug marketed by Ge Healthcare and is included in one NDA.

The generic ingredient in TECHNETIUM TC-99M PENTETATE KIT is technetium tc-99m pentetate kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m pentetate kit profile page.
Summary for TECHNETIUM TC-99M PENTETATE KIT
Drug patent expirations by year for TECHNETIUM TC-99M PENTETATE KIT

US Patents and Regulatory Information for TECHNETIUM TC-99M PENTETATE KIT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare TECHNETIUM TC-99M PENTETATE KIT technetium tc-99m pentetate kit INJECTABLE;INJECTION 017264-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Moodys
Deloitte
Daiichi Sankyo
Novartis
AstraZeneca
McKinsey
Federal Trade Commission
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot